Stock screenerAll disclosures →
EDGAR →
BCRX
Conviction 82HealthcareScan · Mon, Aug 10, 2026Bullish engulfing
BCRX$9.86+5.06%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 3.69M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.86
Change+5.06%
Gap-0.05%
Rel volume3.11×
Avg volume3.7M
Avg $ vol34.73M
SMA 209.34
SMA 509.33
SMA 2008.31
Price vs 50+5.62%
Price vs 200+18.62%
MA stackbullish
50/200 cross—
Supertrenddown · 10.04
RSI (14)57
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D95 / 65
ADX (14)16
+DI / −DI27 / 18
RSI divergence—
MACD divergenceBullish
ATR %+4.58%
ADR %4.18%
52w high11.11
52w low6.24
From 52w high-11.30%
Above 52w low+57.93%
New 52w highNo
SqueezeOn · 2d
Bollinger width11.45%
%B0.98
Donchian pos89.75%
Donchian high9.98
Donchian low8.76
AVWAP (52w high)9.53
vs AVWAP high+3.40%
AVWAP (52w low)8.30
vs AVWAP low+18.70%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d3.11×
Avg vol (14d)3.69M
Avg vol (20d)3.7M
Avg $ vol (20d)34.73M
Market cap2.52B
RS 3m (vs SPY)-0.30%
RS 6m (vs SPY)+36.21%
RS line new highNo
Trend template7/8
Technical rank77.1
1 week+11.86%
1 month-5.69%
3 months+14.33%
6 months+54.47%
1 year+18.02%
YTD+31.40%
P/E9.54
P/B-5.54
P/S99.99
P/FCF7.26
EPS1.21
Div yield—
ROE-58.08%
ROA47.30%
Debt/Eq-0.87
Current2.32
EV/EBITDA8.06
Gross margin—
Net margin—
Rev growth-4.43%
EPS growth396.87%
Price target20.44
Target upside107.41%
Analyst ratingBuy
Institutional109.96%
Ent. value2.76B
Revenue8.76M
Net income78.39M
Gross profit—
Free cash flow347.03M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out254.16M
Employees435
ListedThu, Mar 3, 1994
Free float199.32M
Float %94.6%
Short interest31.21M
Days to cover6.0d
Short volume52.8%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.30 vs $0.14
Last surprise+114.3% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank77.1 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BCRX · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Gilbert Cisneros house · CA · traded 2025-11-13 | Buy | $1K–$15K | 2025-11-13 | 2025-12-12 |
Insider activity
SEC Form 4 transactions in BCRX · 6 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Frank Steven Director · Common Stock · 2026-05-29 | Grant | 1.26K | $11K | 2026-05-29 | 2026-06-02 |
Stonehouse Jon P Director · Common Stock · 2026-05-29 | Grant | 631 | $6K | 2026-05-29 | 2026-06-02 |
Stonehouse Jon P Director · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
MILANO VINCENT Director · Common Stock · 2026-05-29 | Grant | 1.12K | $10K | 2026-05-29 | 2026-06-02 |
McKee Amy E Director · Common Stock · 2026-05-29 | Grant | 631 | $6K | 2026-05-29 | 2026-06-02 |
Milne Jill C. Director · Common Stock · 2026-05-29 | Grant | 1.26K | $11K | 2026-05-29 | 2026-06-02 |
McKee Amy E Director · Common Stock · 2026-05-18 | Sell | 11.18K | $100K | 2026-05-18 | 2026-05-19 |
Barnes Alane P Chief Legal Officer · Emp. Stock Option (Right to Buy) · 2026-05-13 | Exercise | 62.5K | $0 | 2026-05-13 | 2026-05-15 |
Barnes Alane P Chief Legal Officer · Common Stock · 2026-05-13 | Sell | 62.5K | $596K | 2026-05-13 | 2026-05-15 |
Barnes Alane P Chief Legal Officer · Common Stock · 2026-05-13 | Exercise | 62.5K | $315K | 2026-05-13 | 2026-05-15 |
SEC filings
EDGAR filings in BCRX · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.